Skip to main content
Log in

Aminoethane Sulfonic Acid Magnesium Salt Inhibits Ca2+ Entry Through NMDA Receptor Ion Channel In Vitro

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The effect of a cerebroprotective agent magnesium bis-aminoethanesulfonate (laboratory code FS-LKhT-317) on intracellular calcium concentration was studied by the fluorescent imaging technique on neuroglial cell culture from Spraque-Dawley rat hippocampus. The substance produced a pronounced inhibitory effect and suppressed NMDA receptor activity in concentrations of ≥50 μM. The observed effects were reversible or partially reversible and were detected by a decrease in Ca2+ signal amplitude in neurons in response to NMDA applications in a Mg2+-free medium and by inhibition of Ca2+ pulses in magnesium-free medium (elimination of magnesium block).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Blinov DS, Sernov LN, Balashov VP, Blinova EV, Pivkina LV, Gogina ED, Van’kova LV, Vertyankin MV, Boiko GG, Krasilina TV. Antiischemic activity of new domestic antioxidant 3-hydroxypyridine etoxidol derivative. Bull. Exp. Biol. Med. 2012;152(5):583-586.

    Article  CAS  Google Scholar 

  2. Blinov DS, Sernov LN, Blinova EV, Balashov VP, Gogina ED, Van’kova LV, Skachilova SYa, Lebedev AB, Belova LA. Efficiency of Etoxidol in Treating Cardiovascular Disorders Caused by Experimental Cerebral Ischemia. Eksp. Klin. Farmakol. 2011;74(7):13-15. Russian.

  3. Coyle JT. NMDA Receptor and Schizophrenia: a Brief History. Schizophr. Bull. 2012;38(5):920-926.

    Article  Google Scholar 

  4. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol. Rev. 1999;51(1):7-61.

    CAS  PubMed  Google Scholar 

  5. Hallett PJ, Standaert DG. Rationale for and use of NMDA receptor antagonists in Parkinson’s disease. Pharmacol. Ther. 2004;102(2):155-174.

    Article  CAS  Google Scholar 

  6. Hansen KB, Ogden KK, Yuan H, Traynelis SF. Distinct functional and pharmacological properties of triheteromeric GluN1/GluN2A/GluN2B NMDA receptors. Neuron. 2014;81(5):1084-1096.

    Article  CAS  Google Scholar 

  7. Krogh KA, Thayer SA. Calcium imaging to study NMDA receptor-mediated cellular responses. Ionotropic Glutamate Receptor Technologies. Popescu GK, ed. New York, 2016. P. 221-239.

  8. Lindström E, von Mentzer B, Påhlman I, Ahlstedt I, Uvebrant A, Kristensson E, Martinsson R, Novén A, de Verdier J, Vauquelin G. Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo Efficacy. J. Pharmacol. Exp. Ther. 2007;322(3):1286-1293.

    Article  Google Scholar 

  9. Paotti P, Bellone C, ZhouQ. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat. Rev. Neurosci. 2013;14(6):383-400.

    Article  Google Scholar 

  10. Turovsky EA, Turovskaya MV, Kononov AV, Zinchenko VP. Short-term episodes of hypoxia induce posthypoxic hyperexcitability and selective death of GABAergic hippocampal neurons. Exp. Neurol. 2013;250:1-7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. V. Blinova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 7, pp. 46-49, July, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Turovsky, E.A., Blinova, E.V., Semeleva, E.V. et al. Aminoethane Sulfonic Acid Magnesium Salt Inhibits Ca2+ Entry Through NMDA Receptor Ion Channel In Vitro. Bull Exp Biol Med 166, 39–42 (2018). https://doi.org/10.1007/s10517-018-4284-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4284-6

Key Words

Navigation